(Reuters) -U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it ...
Pfizer Inc. (NYSE:PFE) has recently launched a multi-year cost reduction initiative aimed at saving approximately $1.5 billion by the end of 2027. This new program builds upon a $4 billion cost ...
Amid a recent biopharma M&A resurgence, one major player plans to stay out of the waters after making multiple recent ...
What does it even mean for someone to say that it's too late to buy shares of one of the world's biggest and best-known ...
(Reuters) -U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it ...
Pfizer targets $1.5B savings by 2027 with a new cost-cutting plan focusing on operational efficiencies and restructuring. Technical analysis shows bullish momentum for Pfizer's stock, with prices ...
Pfizer Inc. (NYSE:PFE) has recently launched a multi-year cost reduction initiative aimed at saving approximately $1.5 billion by the end of 2027. This new program builds upon a $4 billion cost ...